title: Bimoclomol (BRLP-42) ameliorates peripheral neuropathy in streptozotocin-induced diabetic rats.
abstract: A reduction in nerve conduction velocity and an increase in resistance to ischemic conduction failure are early signs of neural dysfunction in both diabetic patients and animal models of diabetes. The effect of Bimoclomol (BRLP-42), a drug under clinical development for the treatment of diabetic complications, on experimental peripheral neuropathy was examined in rats made diabetic by injection of streptozotocin. Daily oral doses of Bimoclomol (10 or 20 mg/kg) or control dose of gamma-linolenic acid (260 mg/kg), an agent with known neuropathy-improving effects, were administered for 3 months. Treatments began 1 day after diabetes induction to assess the prophylactic efficacy of Bimoclomol. Neuropathy was evaluated electrophysiologically by measuring motor and sensory nerve conduction velocities and resistance to ischemic conduction failure of sciatic nerve in vivo. Bimoclomol significantly reduced nerve conduction slowing and retarded the typical elevated ischaemic resistance due to streptozotocin-induced neuropathy, suggesting that the drug might be a useful treatment for diabetic peripheral neuropathies.
authors.affiliation: Biorex Research & Development Company, Veszprém, Hungary.
authors.forename: K
authors.initials: K
authors.lastname: Bíró
authors.forename: A
authors.initials: A
authors.lastname: Jednákovits
authors.forename: T
authors.initials: T
authors.lastname: Kukorelli
authors.forename: E
authors.initials: E
authors.lastname: Hegedüs
authors.forename: L
authors.initials: L
authors.lastname: Korányi
mesh_terms: D000818:Animals; D001786:Blood Glucose; D003921:Diabetes Mellitus, Experimental / Q000150:complications; D003929:Diabetic Neuropathies / Q000188:drug therapy* / Q000209:etiology; D004576:Electromyography; D007511:Ischemia / Q000188:drug therapy / Q000209:etiology; D008297:Male; D009431:Neural Conduction / Q000187:drug effects; D010879:Piperazines / Q000494:pharmacology*; D011725:Pyridines / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D012584:Sciatic Nerve / Q000098:blood supply / Q000187:drug effects / Q000503:physiopathology; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology*; D017965:gamma-Linolenic Acid / Q000494:pharmacology
chemical_list: C094078:BRLP 42; D001786:Blood Glucose; D010879:Piperazines; D011725:Pyridines; D014665:Vasodilator Agents; D017965:gamma-Linolenic Acid